Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Narang

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|December 1, 1984
Vancomycin disposition: the importance of ageN R Cutler, P K Narang, L J Lesko, et al.
Annals of Neurology|February 1, 1989
Carbamazepine and its epoxide: relation of plasma levels to toxicity and seizure controlW H Theodore, P K Narang, M D Holmes, et al.
Biopharmaceutics & Drug Disposition|July 1, 1983
Systemic bioavailability and pharmacokinetics of methylprednisolone in patients with rheumatoid arthritis following 'high-dose' pulse administrationP K Narang, R Wilder, D C Chatterji, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Lack of effect of concomitant zidovudine on rifabutin kinetics in patients with AIDS-related complexR C Li, S Nightingale, R C Lewis, et al.
Pharmaceutical Research|January 1, 1992
A sensitive and specific procedure for quantitation of ADR-529 in biological fluids by high-performance liquid chromatography (HPLC) with column switching and amperometric detectionR C Lewis, B A Phillips, J R Baldwin, et al.
American Heart Journal|October 1, 1980
Relation of ventricular premature beat suppression to serum quinidine concentraton determined by a new and specific assayN H Carliner, M L Fisher, W G Crouthamel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Influence of the cardioprotective agent dexrazoxane on doxorubicin pharmacokinetics in the dogJ R Baldwin, B A Phillips, S K Overmyer, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokineticsM K Jordan, M A Polis, G Kelly, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 1, 1995
A phase I evaluation of concomitant rifabutin and didanosine in symptomatic HIV-infected patientsJ Sahai, P K Narang, N Hawley-Foss, et al.
Journal of Clinical Pharmacology|November 24, 1998
Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindroneM LeBel, E Masson, E Guilbert, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|December 1, 1984
Vancomycin disposition: the importance of ageN R Cutler, P K Narang, L J Lesko, et al.
Annals of Neurology|February 1, 1989
Carbamazepine and its epoxide: relation of plasma levels to toxicity and seizure controlW H Theodore, P K Narang, M D Holmes, et al.
Biopharmaceutics & Drug Disposition|July 1, 1983
Systemic bioavailability and pharmacokinetics of methylprednisolone in patients with rheumatoid arthritis following 'high-dose' pulse administrationP K Narang, R Wilder, D C Chatterji, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Lack of effect of concomitant zidovudine on rifabutin kinetics in patients with AIDS-related complexR C Li, S Nightingale, R C Lewis, et al.
Pharmaceutical Research|January 1, 1992
A sensitive and specific procedure for quantitation of ADR-529 in biological fluids by high-performance liquid chromatography (HPLC) with column switching and amperometric detectionR C Lewis, B A Phillips, J R Baldwin, et al.
American Heart Journal|October 1, 1980
Relation of ventricular premature beat suppression to serum quinidine concentraton determined by a new and specific assayN H Carliner, M L Fisher, W G Crouthamel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Influence of the cardioprotective agent dexrazoxane on doxorubicin pharmacokinetics in the dogJ R Baldwin, B A Phillips, S K Overmyer, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokineticsM K Jordan, M A Polis, G Kelly, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 1, 1995
A phase I evaluation of concomitant rifabutin and didanosine in symptomatic HIV-infected patientsJ Sahai, P K Narang, N Hawley-Foss, et al.
Journal of Clinical Pharmacology|November 24, 1998
Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindroneM LeBel, E Masson, E Guilbert, et al.
Pageof 6